Sep 06,2016

Insulet Announces Executive Appointments

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced the appointment of Dr. Trang Ly as Insulet's Vice President and Medical Director, effective September 12, 2016. In addition, Brittany Bradrick has been appointed Vice President, Strategy and Corporate Development, a newly-created position, effective September 2, 2016.

View Analyst & Ambassador Comments
Go to original news
Sep 06,2016

Senseonics Appoints Steven V. Edelman, MD to its Board of Directors

Senseonics Holdings, Inc. (NYSE-MKT:SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that Steven Edelman, MD, clinical professor of medicine at the University of California San Diego-Veterans Affairs Healthcare System, has been appointed to its Board of Directors, effective September 2, 2016.

View Analyst & Ambassador Comments
Go to original news
Sep 06,2016

Insulet to Establish Highly-Automated Manufacturing Operation in the United States

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced plans to establish an automated manufacturing operation in the United States and to build product beginning in 2019.

View Analyst & Ambassador Comments
Go to original news
Sep 08,2016

DarioHealth Preps for New iPhone

DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced that it is adapting its flagship product to also incorporate use with the new Apple® iPhone® 7. After receiving regulatory clearance for marketing by the U.S. Food and Drug Administration and other applicable regulatory agencies in Canada, Europe and Australia, customers will be able to select which DarioHealth product they require for connection to their smartphone.

PRODUCT

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 13,2016

Insulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System

Insulet Corporation (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced the first patient has completed the feasibility study of the Omnipod Horizon™ Automated Glucose Control System (Omnipod Horizon System). The full study will evaluate the use of a personal Model Predictive Control algorithm with the Omnipod platform in 20 adults with type 1 diabetes and is taking place in a clinical research center setting to gather data to be used to evolve the algorithm in subsequent studies leading to FDA submission.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Sep 22,2016

BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its insulin syringe manufacturing operations.

View Analyst & Ambassador Comments
Go to original news
Sep 27,2016

DarioHealth Launches New Digital Platform and Online Store in Canada

DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Smart Diabetes Management Solution, today announced the launch of an online store in Canada. This is in collaboration with A&D Medical, a global leader in connected health and biometric measurement devices and services, and Bayshore Specialty Rx Ltd.'s online pharmacy Diabetes Express. While Dario is widely accepted under reimbursement in Canada, this partnership with Bayshore Specialty Rx Ltd. allows for a complete online experience for Dario products and supplies. The full service provided by Diabetes Express, a division of Bayshore Specialty Rx Ltd., includes all handling of the prescription and interaction with the insurers. 

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 27,2016

Insulet Corporation to Announce Third Quarter 2016 Financial Results on November 3, 2016

Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the third quarter of 2016 on November 3, 2016 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Oct 11,2016

Timesulin-maker Patients Pending to launch connected cap for insulin pens next year

Patients Pending, a London-based health startup founded by one of the co-creators of Skype and his brother, has announced that it will follow up its Timesulin insulin pen cap with a Bluetooth-connected insulin pen cap, which the company hopes will help create smart dosing systems for patients with Type 1 diabetes who don’t use an insulin pump.

PRODUCT

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Oct 13,2016

Study shows seniors at risk for diabetes and heart disease lose weight, reduce healthcare costs with Omada's program

The digital behavioral health coaching program from Omada Health has been shown to reduce overweight and obese seniors' risk of developing type 2 diabetes and heart disease by helping them lose weight and adopt healthier behaviors, according to a new study. Over a three-year span, researchers looked at 1,121 adults age 65 or older who had a baseline body mass index of 24 or higher, plus additional risks for diabetes and heart disease, and were enrolled in the Omada digital coaching program.

CLINICAL STUDY

#mobile app

#dtx

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES